Keywords: UK, Trasfer pricing, AstraZeneca, GaxoSmithKline, Avandia

AstraZeneca settles over transfer pricing in UK, agreeing to pay £505 million; GSK slumps on Avandia news

Article | 23 February 2010

Print This

Anglo-Swedish drug major AstraZeneca announced this morning that it has settled a long-running transfer pricing issue with HM Revenue & ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in